Skip to main content
ConductScienceScienceDex
NIH funding notice PA-13-093

Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (STTR)(R41/R42)

Closed on April 5, 2016.

Posted
January 25, 2013
Close date
April 5, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $220,647 in first-year total cost, median $220,647.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IDM-X (10)]1

Most frequent institutions

  1. AURATUS BIO, LLC1
Competing awards under PA-13-093 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2016Development of a STAT2 knock-out hamster model for wild-type filovirus infections1R41OD021979-01ROBL, JAMES MWANG, ZHONGDEAURATUS BIO, LLC, SD$220,647ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
PA-13-093: Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (STTR)(R41/R42) | ScienceDex | ConductScience